Thelansis

Lamellar Ichthyosis Market Outlook Thelansis’s “Lamellar Ichthyosis Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Lamellar Ichthyosis treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Key business questions answered: How can drug development and lifecycle management strategies be optimized across G8 markets (US, EU5, Japan, and China)? How large is the patient population in terms of incidence, prevalence, segments, and those receiving drug treatments? What is the 10-year market outlook for sales and patient share? Which events will have the greatest impact on the market’s trajectory? What...

Lamellar Ichthyosis Market Outlook Thelansis’s “Lamellar Ichthyosis Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Lamellar Ichthyosis treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Lamellar Ichthyosis Overview Lamellar ichthyosis (LI) is a genetically heterogeneous keratinization disorder inherited in an autosomal recessive manner. It is classified as a subtype of autosomal recessive congenital ichthyosis (ARCI), a spectrum of nonsyndromic ichthyoses caused by genetic mutations in various genes. The disease course of LI varies from mild to severe, with severe cases involving complications such as ectropion, eclabium, scarri...

Lamellar ichthyosis (LI) is a genetically heterogeneous keratinization disorder inherited in an autosomal recessive manner. It is classified as a subtype of autosomal recessive congenital ichthyosis (ARCI), a spectrum of nonsyndromic ichthyoses caused by genetic mutations in various genes. The disease course of LI varies from mild to severe, with severe cases involving complications such as ectropion, eclabium, scarring alopecia of the scalp and eyebrows, and palmar and plantar hyperkeratosis. The presenting feature of LI in neonates is a collodion membrane, which eventually dries and peels away, leaving behind a brown, plate-like scale that covers the entire body. The underlying genetic mutations that cause LI have been identified in various genes, including TGM1, ALOX12B, ABCA12, and NIPAL4. Most mutations are found in the TGM1 gene, which encodes transglutaminase 1, a protein forming the epidermal cornified cell envelope. Patients with LI have an average life expectancy. However, sk...